Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL147319 | 0.95 | CYP1A2 (0.46) | CYP1A2FYNCYP2C9CA1CA2 | |
| SCHEMBL1060844 | 0.93 | CYP1A2 (0.46) | CYP1A2FYNCYP2C9CA1CA2 | |
| SCHEMBL42998 | 0.91 | — | — | |
| SCHEMBL144946 | 0.87 | CYP1A2 (0.61) | CYP1A2NOS1NOS2LMNAMAPT | |
| SCHEMBL4393841 | 0.86 | — | — | |
| SCHEMBL9183947 | 0.86 | CYP2C9 (0.37) | CYP1A2FYNCYP2C9NOS3NOS1 | |
| SCHEMBL9183942 | 0.86 | CYP2C9 (0.37) | CYP1A2FYNCYP2C9NOS3NOS1 | |
| SCHEMBL6523445 | 0.85 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL3031906 | 0.85 | CYP1A2 (0.54) | CYP1A2CYP2C9ALDH1A1LMNAMEN1 | |
| SCHEMBL455412 | 0.84 | CYP1A2 (0.52) | CYP1A2ALDH1A1LMNAMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 407 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1379577-B1 | CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES | SOLUTIA INC (US) | 2004-08-25 | — | — | EP | claimed |
| US-6737159-B2 | Controlling solar radiation in safety glass laminates | SOLUTIA, INC. | 2004-05-18 | — | — | US | claimed |
| EP-1379577-A1 | CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES | Solutia Inc. (US) | 2004-01-14 | — | — | EP | claimed |
| US-20020182422-A1 | Controlling solar radiation in safety glass laminates | SOLUTIA INC. | 2002-12-05 | — | — | US | claimed |
| WO-2002077081-A1 | CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES | SOLUTIA, INC. (US) | 2002-10-03 | — | — | WO | claimed |
| CN-115175967-B | Ionic liquids for stabilizing viscosity of silicate-based coatings | 巴斯夫欧洲公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-113330096-B | Use of substituted or unsubstituted polycyclic aromatic compounds for high resolution microscopy | 马克斯·普朗克索赔科学公司 | 2024-05-31 | — | — | CN | disclosed |
| US-11958796-B2 | Hydrophilic and particularly water soluble DBOV-derivatives | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2024-04-16 | — | — | US | disclosed |
| CN-112839922-B | Hydrophilic and in particular water-soluble DBOV derivatives | 马克斯·普朗克索赔科学公司 | 2024-04-02 | — | — | CN | disclosed |
| EP-3183250-B1 | PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | CLAP CO LTD (KR) | 2023-10-04 | — | — | EP | disclosed |
| US-20230303608-A1 | DITHIOLENE METAL COMPLEXES | BASF SCHWEIZ AG (CH) | 2023-09-28 | — | — | US | disclosed |
| EP-4182395-A1 | DITHIOLENE METAL COMPLEXES | BASF SE (DE) | 2023-05-24 | — | — | EP | disclosed |
| US-5079366-A | To derivatize pharmaceutical peptides for transport across the blood/brain barrier | UNIVERSITY OF FLORIDA (US) | 1992-01-07 | — | — | US | disclosed |
| EP-0174956-B1 | SOFT $g(b)-ADRENERGIC BLOCKING AGENTS | BODOR, Nicholas S. (US) | 1990-08-16 | — | — | EP | disclosed |
| US-4888427-A | DIHYDROPYRIDINE-PYRIDINIUM SALT REDOX SYSTEM | UNIVERSITY OF FLORIDA (US) | 1989-12-19 | — | — | US | disclosed |
| US-4829086-A | Soft β-adrenergic blocking agents | IVAX International GmbH (CH) | 1989-05-09 | — | — | US | disclosed |
| EP-0293071-A1 | Redox amino acids and peptides containing them | UNIVERSITY OF FLORIDA (US) | 1988-11-30 | — | — | EP | disclosed |
| EP-0174956-A1 | SOFT -g(b)-ADRENERGIC BLOCKING AGENTS. | BODOR NICHOLAS S | 1986-03-26 | — | — | EP | disclosed |
| WO-1985004168-A1 | SOFT beta-ADRENERGIC BLOCKING AGENTS | BODOR NICHOLAS S | 1985-09-26 | — | — | WO | disclosed |
| US-3971825-A | (5,6) (10,11) BIS-METHYLENE, BRONCHODILATORS | SANKYO COMPANY LIMITED (JA) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303608-A1 | DITHIOLENE METAL COMPLEXES | TST, C1S, F12 | CYP1A2 1684/4885FYN 910/4885CYP2C9 2204/4885 |
| US-11958796-B2 | Hydrophilic and particularly water soluble DBOV-derivatives | NR1H4, HDGF, ABHD16A | CYP1A2 414/4885FYN 3717/4885CYP2C9 331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.